Towards authentic transgenic mouse models of heritable PrP prion diseases. Read more about Towards authentic transgenic mouse models of heritable PrP prion diseases.
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Read more about The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
IDH1 mutation can be present in diffuse astrocytomas and giant cell glioblastomas of young children under 10 years of age. Read more about IDH1 mutation can be present in diffuse astrocytomas and giant cell glioblastomas of young children under 10 years of age.
Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis. Read more about Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis.
Methylation-based classification of benign and malignant peripheral nerve sheath tumors. Read more about Methylation-based classification of benign and malignant peripheral nerve sheath tumors.
Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology. Read more about Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
Somatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen. Read more about Somatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen.
A clinicopathologic study of 11 rosette-forming meningiomas: a rare and potentially confusing pattern. Read more about A clinicopathologic study of 11 rosette-forming meningiomas: a rare and potentially confusing pattern.
Oligodendroglioma: pathology, molecular mechanisms and markers. Read more about Oligodendroglioma: pathology, molecular mechanisms and markers.
Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers. Read more about Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers.
